Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
2.530
+0.040 (1.61%)
May 26, 2026, 12:01 PM EDT - Market open
Codexis Employees
Codexis had 146 employees as of December 31, 2025. The number of employees decreased by 42 or -22.34% compared to the previous year.
Employees
146
Change (1Y)
-42
Growth (1Y)
-22.34%
Revenue / Employee
$534,877
Profits / Employee
-$219,110
Market Cap
229.97M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 146 | -42 | -22.34% | 146 | 0 |
| Dec 31, 2024 | 188 | 14 | 8.05% | 188 | 0 |
| Dec 31, 2023 | 174 | -74 | -29.84% | 174 | 0 |
| Dec 31, 2022 | 248 | -13 | -4.98% | 248 | 0 |
| Dec 31, 2021 | 261 | 80 | 44.20% | 261 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Entrada Therapeutics | 152 |
| LENZ Therapeutics | 152 |
| Voyager Therapeutics | 141 |
| Nkarta | 108 |
| Keros Therapeutics | 87 |
| Cybin | 50 |
| Camp4 Therapeutics | 48 |
CDXS News
- 18 days ago - Codexis reports Q1 EPS (10c), consensus (10c) - TheFly
- 18 days ago - Codexis backs FY26 revenue view $72M-$76M, consensus $74.24M - TheFly
- 18 days ago - Codexis Earnings Call Transcript: Q1 2026 - Transcripts
- 18 days ago - Codexis Earnings release: Q1 2026 - Filings
- 18 days ago - Codexis Quarterly report: Q1 2026 - Filings
- 18 days ago - Codexis Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 27 days ago - Codexis to share RNA manufacturing advances at TIDES USA - GlobeNewsWire
- 4 weeks ago - Codexis Proxy statement: Proxy filing - Filings